Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?

Balli, Mehmet; Tasolar, Hakan; Cetin, Mustafa; Hatem, Engin; ÇAĞLIYAN, ÇAĞLAR; Seker, Taner; Cayli, Murat

doi:10.1016/j.jjcc.2015.09.018

Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?

Balli M., Tasolar H., Cetin M., Hatem E., ÇAĞLIYAN Ç. E., Seker T., ...Daha Fazla

JOURNAL OF CARDIOLOGY, cilt.67, ss.327-330, 2016 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 67
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.jjcc.2015.09.018
Dergi Adı: JOURNAL OF CARDIOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.327-330
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Çukurova Üniversitesi Adresli: Evet

Özet

Background: Contrast-induced nephropathy (CIN) is an iatrogenic problem in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Atrial fibrillation (AF) may also contribute to impaired kidney function. Several factors may contribute to the development of CIN. In patients with STEMI, concomitant AF is associated with higher in-hospital/follow-up mortality and morbidity. Therefore, we aimed to investigate the relationship between AF and CIN developments.